Cargando…
Whole-Exome Sequencing Reveals Clinical Potential of Circulating Tumor DNA from Peritoneal Fluid and Plasma in Endometrial Cancer
SIMPLE SUMMARY: Studies on biomarkers for endometrial cancer using circulating tumor DNA (ctDNA) from liquid biopsy samples are lacking. The aim of this study was to analyze gDNA from tumor tissues and ctDNA derived from peritoneal fluid and plasma samples and determine their mutational concordance...
Autores principales: | Ju, Hye-Yeon, Ho, Jung Yoon, Kang, Jun, Hur, Soo Young, Kim, Sejin, Choi, Youn Jin, Han, Mi-Ryung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139435/ https://www.ncbi.nlm.nih.gov/pubmed/35626111 http://dx.doi.org/10.3390/cancers14102506 |
Ejemplares similares
-
Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer
por: Han, Mi-Ryung, et al.
Publicado: (2020) -
Assessment of circulating tumor DNA in cerebrospinal fluid by whole exome sequencing to detect genomic alterations of glioblastoma
por: Duan, Hao, et al.
Publicado: (2020) -
Optimized detection of insertions/deletions (INDELs) in whole-exome sequencing data
por: Kim, Bo-Young, et al.
Publicado: (2017) -
Findings of a 1303 Korean whole-exome sequencing study
por: Kwak, Soo Heon, et al.
Publicado: (2017) -
Ferritin as a predictor of decline in residual renal function in peritoneal dialysis patients
por: Hur, Soon Mi, et al.
Publicado: (2014)